A detailed history of Pacifica Partners Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pacifica Partners Inc. holds 2,182 shares of ABBV stock, worth $437,512. This represents 0.18% of its overall portfolio holdings.

Number of Shares
2,182
Previous 2,182 -0.0%
Holding current value
$437,512
Previous $374,000 14.97%
% of portfolio
0.18%
Previous 0.17%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $66,795 - $77,325
500 Added 29.73%
2,182 $325,000
Q1 2022

Apr 12, 2022

SELL
$131.98 - $163.75 $65,990 - $81,875
-500 Reduced 22.91%
1,682 $247,000
Q2 2021

Jul 14, 2021

BUY
$105.21 - $117.21 $5,260 - $5,860
50 Added 2.35%
2,182 $248,000
Q1 2021

Apr 08, 2021

BUY
$102.3 - $112.62 $137,388 - $151,248
1,343 Added 170.22%
2,132 $225,000
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $18,110 - $24,450
225 Added 39.89%
789 $82,000
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $40,681 - $50,901
564 New
564 $50,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pacifica Partners Inc. Portfolio

Follow Pacifica Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacifica Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacifica Partners Inc. with notifications on news.